Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure

doi:10.1007/s00134-020-06177-1

Comment

. 2020 Oct;46(10):1924-1926.

doi: 10.1007/s00134-020-06177-1. Epub 2020 Jul 15.

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure

Noémie Zucman¹, Jimmy Mullaert², Damien Roux³, Oriol Roca⁴, Jean-Damien Ricard⁵; Contributors

Collaborators, Affiliations

Collaborators

Contributors:
Dan Longrois, Didier Dreyfuss

Affiliations

¹ Assistance Publique-Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Medico-Surgical ICU, Louis Mourier Hospital, 92700, Colombes, France.
² Assistance Publique-Hôpitaux de Paris, Department of Epidemiology, Biostatistics and Clinical Research, Hôpital Bichat, 75018, Paris, France.
³ Université de Paris, IAME, INSERM, UMR 1137, Paris, France.
⁴ Critical Care Department, Vall D'Hebron University Hospital, Vall D'Hebron Research Institute, 08035, Barcelona, Spain.
⁵ Assistance Publique-Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Medico-Surgical ICU, Louis Mourier Hospital, 92700, Colombes, France. jean-damien.ricard@aphp.fr.

PMID: 32671470
PMCID: PMC7362315
DOI: 10.1007/s00134-020-06177-1

Comment

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure

Noémie Zucman et al. Intensive Care Med. 2020 Oct.

. 2020 Oct;46(10):1924-1926.

doi: 10.1007/s00134-020-06177-1. Epub 2020 Jul 15.

Authors

Noémie Zucman¹, Jimmy Mullaert², Damien Roux³, Oriol Roca⁴, Jean-Damien Ricard⁵; Contributors

Collaborators

Contributors:
Dan Longrois, Didier Dreyfuss

Affiliations

¹ Assistance Publique-Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Medico-Surgical ICU, Louis Mourier Hospital, 92700, Colombes, France.
² Assistance Publique-Hôpitaux de Paris, Department of Epidemiology, Biostatistics and Clinical Research, Hôpital Bichat, 75018, Paris, France.
³ Université de Paris, IAME, INSERM, UMR 1137, Paris, France.
⁴ Critical Care Department, Vall D'Hebron University Hospital, Vall D'Hebron Research Institute, 08035, Barcelona, Spain.
⁵ Assistance Publique-Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Medico-Surgical ICU, Louis Mourier Hospital, 92700, Colombes, France. jean-damien.ricard@aphp.fr.

PMID: 32671470
PMCID: PMC7362315
DOI: 10.1007/s00134-020-06177-1

No abstract available

PubMed Disclaimer

Conflict of interest statement

JDR received travel expenses and accommodation coverage from Fisher & Paykel Healthcare to attend scientific meetings. Fisher & Paykel Healthcare provided support for the ongoing High Flow ACRF trial (NCT03406572) but took no part in design or conduct of the study. OR received speaker fees from Air Liquide. His institution received consultancy fees from Hamilton Medical. DR received personal fees from Astellas. Other authors have no conflict of interest.

Figures

**Fig. 1**
Cumulative incidence of orotracheal intubation for all at-risk patients (N = 60) and after 4 h of NHF (N = 45) stratified on ROX-H0H4 (landmark at H4). NHF, nasal high flow. ROX-H0H4 was defined as the latest value of the ROX index within the first 4 h after NHF initiation

See this image and copyright information in PMC

Comment on

An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.
Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, García-de-Acilu M, Frat JP, Masclans JR, Ricard JD. Roca O, et al. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC. Am J Respir Crit Care Med. 2019. PMID: 30576221

Cited by

Risk factors for mechanical ventilation and ECMO in COVID-19 patients admitted to the ICU: A multicenter retrospective observational study.
Takada R, Takazawa T, Takahashi Y, Fujizuka K, Akieda K, Saito S. Takada R, et al. PLoS One. 2022 Nov 14;17(11):e0277641. doi: 10.1371/journal.pone.0277641. eCollection 2022. PLoS One. 2022. PMID: 36374929 Free PMC article.
Predictive factors associated with high-flow nasal cannula success for COVID-19-related acute hypoxemic respiratory failure.
Goury A, Moussanang JA, Bard M, Champenois V, Julien G, Dupont V, Mourvillier B. Goury A, et al. Health Sci Rep. 2021 May 7;4(2):e287. doi: 10.1002/hsr2.287. eCollection 2021 Jun. Health Sci Rep. 2021. PMID: 33977167 Free PMC article. No abstract available.
Factors Associated With Non-invasive Oxygen Therapy Failure in COVID-19 Pneumonia: A Single Center, Retrospective Study in a Tertiary Hospital in North India.
L S, Sehgal IS, Kajal K, Kataria S, Premkumar M, Singla K, Mahajan V, Gorla DK, Puri GD. L S, et al. Cureus. 2022 Sep 28;14(9):e29721. doi: 10.7759/cureus.29721. eCollection 2022 Sep. Cureus. 2022. PMID: 36340560 Free PMC article.
ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.
Ferrer S, Sancho J, Bocigas I, Bures E, Mora H, Monclou E, Mulet A, Quezada A, Royo P, Signes-Costa J. Ferrer S, et al. Respir Med. 2021 Nov-Dec;189:106638. doi: 10.1016/j.rmed.2021.106638. Epub 2021 Oct 6. Respir Med. 2021. PMID: 34634500 Free PMC article.
Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia.
Dupuis C, Bouadma L, de Montmollin E, Goldgran-Toledano D, Schwebel C, Reignier J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Grapin K, Laurent V, Buetti N, Gainnier M, Souweine B, Timsit JF. Dupuis C, et al. Crit Care Explor. 2021 Jan 22;3(1):e0329. doi: 10.1097/CCE.0000000000000329. eCollection 2021 Jan. Crit Care Explor. 2021. PMID: 33521646 Free PMC article.

See all "Cited by" articles

References

1. Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi: 10.1001/jama.2020.5394. - DOI - PMC - PubMed
1. Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020;46:854–887. doi: 10.1007/s00134-020-06022-5. - DOI - PMC - PubMed
1. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102. doi: 10.1007/s00134-020-06033-2. - DOI - PMC - PubMed
1. Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199:1368–1376. doi: 10.1164/rccm.201803-0589OC. - DOI - PubMed
1. Ottestad W, Søvik S. COVID-19 patients with respiratory failure: what can we learn from aviation medicine? Br J Anaesth. 2020 doi: 10.1016/j.bja.2020.04.012. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi: 10.1001/jama.2020.5394. - DOI - PMC - PubMed

[2] Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi: 10.1001/jama.2020.5394. - DOI - PMC - PubMed

[3] Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020;46:854–887. doi: 10.1007/s00134-020-06022-5. - DOI - PMC - PubMed

[4] Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020;46:854–887. doi: 10.1007/s00134-020-06022-5. - DOI - PMC - PubMed

[5] Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102. doi: 10.1007/s00134-020-06033-2. - DOI - PMC - PubMed

[6] Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102. doi: 10.1007/s00134-020-06033-2. - DOI - PMC - PubMed

[7] Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199:1368–1376. doi: 10.1164/rccm.201803-0589OC. - DOI - PubMed

[8] Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199:1368–1376. doi: 10.1164/rccm.201803-0589OC. - DOI - PubMed

[9] Ottestad W, Søvik S. COVID-19 patients with respiratory failure: what can we learn from aviation medicine? Br J Anaesth. 2020 doi: 10.1016/j.bja.2020.04.012. - DOI - PMC - PubMed

[10] Ottestad W, Søvik S. COVID-19 patients with respiratory failure: what can we learn from aviation medicine? Br J Anaesth. 2020 doi: 10.1016/j.bja.2020.04.012. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure

Collaborators

Affiliations

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure

Authors

Collaborators

Affiliations

Conflict of interest statement

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical